The Department of Health has announced that the UK has now rolled out the biggest trial of possible coronavirus treatments in the world, with nearly 1,000 patients from 132 different hospitals recruited in just 15 days.
Numerous medications recommended by a panel of experts giving advice to the chief medical officer for England are now being tested, including Lopinavir-Ritonavir (used to treat HIV), Dexamethasone (a steroid used to reduce inflammation in a range of different conditions) and hydroxychloroquine (which is used to treat malaria).
The study has received £2.1 million from UK Research and Innovation and the Department of Health and Social Care, part of a wider £20 million rapid research response investment to support finding new ways to tackle the outbreak.
This comes after the Medicines and Healthcare Products Regulatory Agency fast-tracked clinical trials for potential treatments, meaning that patients could see faster access if medicines are found to be effective.
“The Recovery trial will provide much-needed evidence on the best care for patients with COVID-19. The more patients that are enrolled, the sooner we will know how best to treat this disease.
“We are very grateful to those patients who are participating and to the hospital and research staff who are helping us to find the best treatments,” Peter Horby, professor of emerging infectious diseases and global health at the Nuffield Department of Medicine at Oxford University, said.
Speaking to the Daily Telegraph earlier this month (April 6th), researchers from the university intimated that in a best case scenario a vaccine could be ready as early as the autumn.
Need the help of life science recruiters? Get in touch with us today.